Skip to main content

Advertisement

Log in

Assessment and management of disability in chronic daily headache

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

The problem of chronic daily headache is ubiquitous and affects up to 5% of the world’s population. In most cases, it is associated with the overuse of symptomatic medications in patients with a history of migraine or tension-type headaches, indicating an urgent need for intensive public and professional education. In a minority, it develops de novo from episodic migraine without excessive drug intake. The condition is likely to have a biologic (rather than psychologic) basis. The degree with which it negatively impacts patients and their family is reviewed. Current treatment régimes are described, but it is noted that those currently employed are seldom adequate in the long term, possibly because of the unavailability of nonpharmacologic treatments to most people or because of the low frequency of use of preventative pharmacologic and lifestyle measures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Gladstone J, Eross E, Dodick DW: Chronic daily headache: a rational approach to a challenging problem. Semin Neurol 2003, 23:265–276. A timely and comprehensive examination of the diagnosis and management of these conditions.

    Article  PubMed  Google Scholar 

  2. Chakravarty A: Chronic daily headaches: clinical profile in Indian patients. Cephalalgia 2003, 23:348–353.

    Article  PubMed  CAS  Google Scholar 

  3. Dowson A: Analysis of the patients attending a specialist UK headache clinic over a 3-year period. Headache 2003, 43:14–18.

    Article  PubMed  Google Scholar 

  4. Krymchantowski AV: Primary headache diagnosis among chronic daily headache patients. Arq Neuropsiquiatr 2003, 61:364–367.

    PubMed  Google Scholar 

  5. Lanteri-Minet M, Auray JP, El Hasnaoui A, et al.: Prevalence and description of chronic daily headache in the general population in France. Pain 2003, 102:143–149.

    Article  PubMed  Google Scholar 

  6. Flippen CC: Pearls and pitfalls of headaches. Semin Neurol 2001, 21:371–376.

    Article  PubMed  Google Scholar 

  7. Beghi E, Monticelli ML, Amoruso L, et al.: Prevalence, characteristics, and patterns of health care use for chronic headaches in two areas of Italy: results of a questionnaire interview in general practice. Cephalalgia 2003, 23:175–182.

    Article  PubMed  CAS  Google Scholar 

  8. Diener HC, Limmroth V: Medication-overuse headache: a worldwide problem. Lancet 2004, 3:475–483. The authors delineate the scope and significance of CDH worldwide.

    Article  Google Scholar 

  9. Lu SR, Fuh JL, Chen WT, et al.: Chronic daily headache in Taipei, Taiwan: prevalence, follow-up, and outcome predictors. Cephalalgia 2001, 21:980–986.

    Article  PubMed  CAS  Google Scholar 

  10. Colas R, Munoz P, Temprano R, et al.: Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 2004, 62:1338–1342.

    PubMed  CAS  Google Scholar 

  11. Scher AI, Stewart WF, Ricci JA, Lipton RB: Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003, 106:81–89.

    Article  PubMed  CAS  Google Scholar 

  12. Hershey AD: Chronic daily headaches in children. Expert Opin Pharmacother 2003, 4:485–491.

    Article  PubMed  CAS  Google Scholar 

  13. Esposito SB, Gherpelli JL: Chronic daily headaches in children and adolescents: a study of clinical characteristics. Cephalalgia 2004, 24:476–482.

    Article  PubMed  CAS  Google Scholar 

  14. Gladstein J: Children and adolescents with chronic daily headache. Curr Pain Headache Rep 2004, 8:71–75.

    Article  PubMed  Google Scholar 

  15. Gordon KE, Dooley JM, Wood EP: Self-reported headache frequency and features associated with frequent headaches in Canadian young adolescents. Headache 2004, 44:555–561.

    Article  PubMed  CAS  Google Scholar 

  16. Silberstein S, Lipton R, Nalessio D: Wolff’s Headache and Other Head Pain, edn 7. Oxford: Oxford University Press; 2001.

    Google Scholar 

  17. Relja G, Granato M, Maria Antonella R, Zorzon M: Headache induced by chronic substance use: analysis of medication overused and minimum dose required to induce headache. Headache 2004, 6:580.

    Google Scholar 

  18. Silberstein SD, Lipton RB, Sliwinski M: Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996, 47:871–875.

    PubMed  CAS  Google Scholar 

  19. Olesen J, Bousser MG, Diener HC, et al.: The International Classification of Headache Disorders, edn 2. Cephalalgia 2004, 24:S1-S160.

    Article  Google Scholar 

  20. Levin M: Chronic daily headache and the revised international headache society classification. Curr Pain Headache Rep 2004, 8:59–65.

    Article  PubMed  Google Scholar 

  21. Stewart WF, Lipton RB, Whyte J, et al.: An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 1999, 53:988–994.

    PubMed  CAS  Google Scholar 

  22. Jacobson GP, Ramadan NM, Aggarwal SK, Newman CW: Henry Ford Hospital Headache Disability Inventory. Neurology 1994, 44:837–842.

    PubMed  CAS  Google Scholar 

  23. Ware JE: SF-36 Health Survey Manual and Interpretation Guide: 1. Boston: The Health Institute, New England Medical Centers Hospitals Inc; 2004.

    Google Scholar 

  24. Wagner TH, Patrick DL, Galer BS: A new instrument to assess the long-term quality of life effects from migraine: development and psychometric testing of the MSQOL. Headache 1996, 36:484–492.

    Article  PubMed  CAS  Google Scholar 

  25. Jhingran P, Osterhaus JT, Miller DW, et al.: Development and validation of the Migraine-specific Quality of Life Questionnaire. Headache 1998, 38:295–302.

    Article  PubMed  CAS  Google Scholar 

  26. Hartmaier SL, Santanello NC, Epstein RS, et al.: Development of a brief 24-hour migraine-specific quality-of-life questionnaire. Headache 1995, 35:320–329.

    Article  PubMed  CAS  Google Scholar 

  27. Montagna P, Cevoli S, Marzocchi N, et al.: The genetics of chronic headaches. Neurol Sci 2003, 24:S51-S56.

    PubMed  Google Scholar 

  28. Gallai V, Alberti A, Gallai B, et al.: Glutamate and nitric oxide pathway in chronic daily headache: evidence from cerebrospinal fluid. Cephalalgia 2003, 23:166–174.

    Article  PubMed  CAS  Google Scholar 

  29. Bahra A, Walsh M, Menon S, Goadsby PJ: Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 2003, 43:179–190.

    Article  PubMed  Google Scholar 

  30. Bigal ME, Rapoport AM, Sheftell FD, et al.: Transformed migraine and medication overuse in a tertiary headache centre: clinical characteristics and treatment outcomes. Cephalalgia 2004, 24:483–490.

    Article  PubMed  CAS  Google Scholar 

  31. Peres MF, Zuckerman E, Young WB, Silberstein SD: Fatigue in chronic migraine patients. Cephalalgia 2002, 22:720–724.

    Article  PubMed  CAS  Google Scholar 

  32. Atasoy HT, Atasoy N, Unal AE, et al.: Psychiatric comorbidity in medication overuse headache patients with pre-existing headache type of episodic tension-type headache. Eur J Pain 2004, in press.

  33. D’Amico D, Usai S, Grazzi L, et al.: Quality of life and disability in primary chronic headaches. Neurol Sci 2003, 24:S97-S100.

    Article  PubMed  Google Scholar 

  34. Bigal ME, Rapoport AM, Lipton RB, et al.: Assessment of migraine disability using the Migraine Disability Assessment (MIDAS) Questionnaire: a comparison of chronic migraine with episodic migraine. Headache 2003, 43:336–342.

    Article  PubMed  Google Scholar 

  35. Duru G, Auray JP, Gaudin AF, et al.: Impact of headache on quality of life in a general population survey in France (GRIM2000 Study). Headache 2004, 44:571–580.

    Article  PubMed  Google Scholar 

  36. Guitera V, Munoz P, Castillo J, Pascual J: Quality of life in chronic daily headache: a study in a general population. Neurology 2002, 58:1062–1065.

    PubMed  Google Scholar 

  37. Monzon MJ, Lainez MJ: Quality of life in migraine and chronic daily headache patients. Cephalalgia 1998, 18:638–643.

    Article  PubMed  CAS  Google Scholar 

  38. Wang SJ, Fuh JL, Lu SR, Juang KD: Quality of life differs among headache diagnoses: analysis of SF-36 survey in 901 headache patients. Pain 2001, 89:285–292.

    Article  PubMed  CAS  Google Scholar 

  39. Meletiche DM, Lofland JH, Young WB: Quality-of-life differences between patients with episodic and transformed migraine. Headache 2001, 41:573–578.

    Article  PubMed  CAS  Google Scholar 

  40. Cassidy EM, Tomkins E, Hardiman O, O’Keane V: Factors associated with burden of primary headache in a specialty clinic. Headache 2003, 43:638–644.

    Article  PubMed  Google Scholar 

  41. Bigal ME, Sheftell FD, Rapoport AM, et al.: Chronic daily headache: identification of factors associated with induction and transformation. Headache 2002, 42:575–581.

    Article  PubMed  Google Scholar 

  42. Harpole LH, Samsa GP, Jurgelski AE, et al.: Headache management program improves outcome for chronic headache. Headache 2003, 43:715–724.

    Article  PubMed  Google Scholar 

  43. Magnusson JE, Reis CM, Becker WJ: Effectiveness of a multidisciplinary treatment program for chronic daily headache. Can J Neurol Sci 2004, 31:72–79.

    PubMed  Google Scholar 

  44. Williams DR, Stark RJ: Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalalgia 2003, 23:963–971.

    Article  PubMed  CAS  Google Scholar 

  45. Krymchantowski AV, Moreira PF: Outpatient detoxification in chronic migraine. Cephalalgia 2003, 23:982–993.

    Article  PubMed  CAS  Google Scholar 

  46. Ondo WG, Vuong KD, Derman HS: Botulinum toxin A for chronic daily headache: a randomised, placebo-controlled parallel design study. Cephalalgia 2004, 24:60–65.

    Article  PubMed  CAS  Google Scholar 

  47. Padberg M, de Bruijn SF, de Haan RJ, Tavy DL: Treatment of chronic tension tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial. Cephalalgia 2004, 24:675–680.

    Article  PubMed  CAS  Google Scholar 

  48. Green SH: Chronic and recurrent headache. Curr Pediatr 2002, 12:186–190.

    Article  Google Scholar 

  49. Grazzi L, Usai S, Bussone G: Chronic headache in young patients: clinical aspects and treatment suggestions. Neurol Sci 2003, 24(suppl `2):S112-S114.

    PubMed  Google Scholar 

  50. Fritsche G, Diener HC: Medication overuse headaches: What is new? Exp Opin Drug Safety 2002, 1:331–338.

    Article  Google Scholar 

  51. Schnider P, Aull S, Baumgartner C, et al.: Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: 5-year follow-up. Cephalalgia 1996, 16:481–485.

    Article  PubMed  CAS  Google Scholar 

  52. Linton-Dahlof P, Linde M, Dahlof C: Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study. Cephalalgia 2000, 20:658–662.

    Article  PubMed  CAS  Google Scholar 

  53. Pini LA, Cicero AF, Sandrini M: Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia 2001, 21:878–883.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pryse-Phillips, W. Assessment and management of disability in chronic daily headache. Current Science Inc 9, 53–58 (2005). https://doi.org/10.1007/s11916-005-0075-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-005-0075-7

Keywords

Navigation